James B. Young

66.8k total citations · 26 hit papers
636 papers, 48.4k citations indexed

About

James B. Young is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Biomedical Engineering. According to data from OpenAlex, James B. Young has authored 636 papers receiving a total of 48.4k indexed citations (citations by other indexed papers that have themselves been cited), including 360 papers in Cardiology and Cardiovascular Medicine, 229 papers in Surgery and 100 papers in Biomedical Engineering. Recurrent topics in James B. Young's work include Heart Failure Treatment and Management (173 papers), Transplantation: Methods and Outcomes (130 papers) and Mechanical Circulatory Support Devices (98 papers). James B. Young is often cited by papers focused on Heart Failure Treatment and Management (173 papers), Transplantation: Methods and Outcomes (130 papers) and Mechanical Circulatory Support Devices (98 papers). James B. Young collaborates with scholars based in United States, United Kingdom and Canada. James B. Young's co-authors include Lewis Landsberg, William T. Abraham, Lynne W. Stevenson, David C. Naftel, James K. Kirklin, Randall C. Starling, Francis D. Pagani, Robert L. Kormos, Marissa A. Miller and Nancy M. Albert and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

James B. Young

619 papers receiving 46.3k citations

Hit Papers

Contemporary Definitions ... 1978 2026 1994 2010 2006 2003 2009 1981 2015 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Contemporary Definitions and Classification of the Cardiomyopathies
    2006 2.2k citations James B. Young et al. Circulation profile →
  2. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
    2003 1.2k citations James B. Young et al. PubMed profile →
  3. Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure
    2009 1.1k citations Wilfried Müllens, Randall C. Starling et al. profile →
  4. Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man
    1981 995 citations James B. Young, Lewis Landsberg et al. profile →
  5. Seventh INTERMACS annual report: 15,000 patients and counting
    2015 936 citations James B. Young et al. profile →
  6. Eighth annual INTERMACS report: Special focus on framing the impact of adverse events
    2017 843 citations James B. Young et al. profile →
  7. Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart
    1996 831 citations Guillermo Torre‐Amione, James B. Young et al. Circulation profile →
  8. Cytokines and Cytokine Receptors in Advanced Heart Failure
    2001 826 citations James B. Young et al. Circulation profile →
  9. Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure
    2007 799 citations Gregg C. Fonarow, Wendy Gattis Stough et al. profile →
  10. Differences in Tachyarrhythmia Detection and Implantable Cardioverter Defibrillator Therapy by Primary or Secondary Prevention Indication in Cardiac Resynchronization Therapy Patients
    2004 756 citations James B. Young, William T. Abraham et al. Journal of Cardiovascular Electrophysiology profile →
  11. Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure
    2006 713 citations Mihai Gheorghiade, William T. Abraham et al. profile →
  12. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure
    2004 706 citations William T. Abraham, Christopher M. O’Connor et al. profile →
  13. Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure
    1999 662 citations Robert S. McKelvie, Salim Yusuf et al. Circulation profile →
  14. Sixth INTERMACS annual report: A 10,000-patient database
    2014 606 citations James B. Young et al. profile →
  15. Anthracycline-Induced Cardiotoxicity
    1996 589 citations James B. Young et al. profile →
  16. Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme Inhibitors
    1993 553 citations Mihai Gheorghiade, James B. Young et al. profile →
  17. Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-controlled Study
    2011 547 citations James B. Young et al. profile →
  18. Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients
    2013 533 citations James B. Young et al. profile →
  19. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
    2008 503 citations Eric L. Michelson, James B. Young et al. profile →
  20. High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults
    2001 501 citations James B. Young et al. Circulation profile →
  21. INTERMACS Profiles of Advanced Heart Failure: The Current Picture
    2009 486 citations James B. Young et al. profile →
  22. Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure
    2007 457 citations Scott D. Solomon, Joanna Dobson et al. Circulation profile →
  23. Predictors of In-Hospital Mortality in Patients Hospitalized for Heart Failure
    2008 434 citations William T. Abraham, Gregg C. Fonarow et al. profile →
  24. Fasting, Feeding and Regulation of the Sympathetic Nervous System
    1978 424 citations Lewis Landsberg, James B. Young profile →
  25. Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial
    2011 400 citations James B. Young et al. profile →
  26. Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure
    2013 400 citations Karl Swedberg, James B. Young et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
James B. Young 29.4k 13.5k 8.6k 5.2k 4.7k 636 48.4k
William T. Abraham 49.4k 1.7× 9.5k 0.7× 5.3k 0.6× 4.3k 0.8× 9.0k 1.9× 692 59.9k
Lynne W. Stevenson 37.5k 1.3× 13.7k 1.0× 10.5k 1.2× 1.4k 0.3× 5.7k 1.2× 388 49.3k
Gerhard Schüler 25.5k 0.9× 12.3k 0.9× 4.1k 0.5× 4.0k 0.8× 5.6k 1.2× 652 40.9k
Andrew J.S. Coats 40.4k 1.4× 7.2k 0.5× 4.1k 0.5× 6.7k 1.3× 6.4k 1.4× 660 54.4k
Michael Böhm 37.8k 1.3× 14.1k 1.0× 3.6k 0.4× 4.5k 0.9× 6.2k 1.3× 1.1k 61.6k
Donna Mancini 19.1k 0.6× 14.8k 1.1× 11.1k 1.3× 1.8k 0.3× 3.1k 0.6× 483 35.2k
Eugene Braunwald 36.2k 1.2× 14.8k 1.1× 4.7k 0.5× 4.8k 0.9× 5.7k 1.2× 498 51.7k
Christian Torp‐Pedersen 32.3k 1.1× 7.4k 0.5× 2.3k 0.3× 3.0k 0.6× 4.3k 0.9× 1.3k 52.4k
Lars Køber 39.2k 1.3× 10.5k 0.8× 3.2k 0.4× 2.8k 0.5× 5.6k 1.2× 1.4k 59.4k
Gerasimos Filippatos 30.8k 1.0× 6.3k 0.5× 3.1k 0.4× 2.5k 0.5× 7.5k 1.6× 625 43.8k

Countries citing papers authored by James B. Young

Since Specialization
Citations

This map shows the geographic impact of James B. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James B. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James B. Young more than expected).

Fields of papers citing papers by James B. Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James B. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James B. Young. The network helps show where James B. Young may publish in the future.

Co-authorship network of co-authors of James B. Young

This figure shows the co-authorship network connecting the top 25 collaborators of James B. Young. A scholar is included among the top collaborators of James B. Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James B. Young. James B. Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalgaard, Frederik, Marat Fudim, Sana M. Al‐Khatib, et al.. (2023). Cardiac resynchronization therapy in patients with a prior history of atrial fibrillation: Insights from four major clinical trials. Journal of Cardiovascular Electrophysiology. 34(9). 1914–1924. 2 indexed citations
2.
Hendren, Nicholas, Matthew W. Segar, Lin Zhong, et al.. (2021). Phenomapping a Novel Classification System for Patients With Destination Therapy Left Ventricular Assist Devices. The American Journal of Cardiology. 164. 93–99. 2 indexed citations
3.
Falter, Maarten, Henri Gruwez, & James B. Young. (2021). The future is more than a digital stethoscope. European Heart Journal - Digital Health. 2(4). 557–558. 1 indexed citations
4.
Michelis, Katherine C., Lin Zhong, Matthias Peltz, et al.. (2020). Dynamic Forecasts of Survival for Patients Living With Destination Left Ventricular Assist Devices: Insights From INTERMACS. Journal of the American Heart Association. 9(14). e016203–e016203. 3 indexed citations
5.
Chung, Mina K., Sadashiva S. Karnik, Cornelia C. Bergmann, et al.. (2020). SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy. EBioMedicine. 58. 102907–102907. 96 indexed citations
6.
Young, James B., Marjolaine Gauthier‐Loiselle, Robert A. Bailey, et al.. (2018). Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data. Cardiovascular Diabetology. 17(1). 118–118. 31 indexed citations
7.
Bello, Natalie A., Eldrin F. Lewis, Akshay S. Desai, et al.. (2015). Increased Risk of Stroke with Darbepoetin Alfa in Anaemic Heart Failure Patients with Diabetes and Chronic Kidney Disease. European Journal of Heart Failure. 17(11). 1201–1207. 34 indexed citations
8.
Verbrugge, Frederik H., Matthias Dupont, Wilfried Müllens, et al.. (2015). Response and Tolerance to Oral Vasodilator Up-Titration After Intravenous Vasodilator Therapy in Advanced Decompensated Heart Failure. European Journal of Heart Failure. 17(9). 956–963. 6 indexed citations
9.
McMurray, John J.V., Inder S. Anand, Rafael Díaz, et al.. (2013). Baseline Characteristics of Patients in the Reduction of Events with Darbepoetin Alfa in Heart Failure Trial (RED-HF). European Journal of Heart Failure. 15(3). 334–341. 23 indexed citations
10.
Vest, Amanda R., Helen Heneghan, Shikhar Agarwal, Philip R. Schauer, & James B. Young. (2012). Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 98(24). 1763–1777. 244 indexed citations
11.
12.
13.
Solomon, Scott D., Joanna Dobson, Stuart Pocock, et al.. (2007). Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure. Circulation. 116(13). 1482–1487. 457 indexed citations breakdown →
14.
Ahmed, Ali, Michael W. Rich, Jerome L. Fleg, et al.. (2006). Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure. Circulation. 114(5). 397–403. 420 indexed citations
15.
Lewis, Eldrin F., Gervasio A. Lamas, Eileen O’Meara, et al.. (2006). Characterization of Health-Related Quality of Life in Heart Failure Patients with Preserved Versus Low Ejection Fraction in CHARM. European Journal of Heart Failure. 9(1). 83–91. 179 indexed citations
16.
Spurr, E. B., Shaun Ogilvie, Chris W. Morse, & James B. Young. (2005). Development of a toxic bait for control of ferrets ( Mustela furo ) in New Zealand. New Zealand Journal of Zoology. 32(2). 127–136. 6 indexed citations
17.
Hoercher, Katherine J., P. McCarthy, & James B. Young. (1999). Cardiac transplantation at the Cleveland Clinic Foundation.. PubMed. 239–48. 3 indexed citations
18.
Snitker, Søren, Johan Hellmér, Michael Boschmann, et al.. (1998). In SituLipolytic Responses to Isoproterenol and Physiological Stressors Are Similar in Obese Pima Indians and Caucasians. The Journal of Clinical Endocrinology & Metabolism. 83(11). 4054–4058. 2 indexed citations
19.
Ward, Kenneth D., David Sparrow, Lewis Landsberg, et al.. (1994). The relationship of epinephrine excretion to serum lipid levels: The normative aging study. Metabolism. 43(4). 509–513. 33 indexed citations
20.
Boyce, John M., et al.. (1977). An Epizootiologic Study of Anthrax in Falls County, Texas. Journal of the American Veterinary Medical Association. 170(3). 327–333. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William T. Abraham Breakdown of academic impact, for papers by Lynne W. Stevenson Breakdown of academic impact, for papers by Gerhard Schüler Breakdown of academic impact, for papers by Andrew J.S. Coats Breakdown of academic impact, for papers by Michael Böhm Breakdown of academic impact, for papers by Donna Mancini Breakdown of academic impact, for papers by Eugene Braunwald Breakdown of academic impact, for papers by Christian Torp‐Pedersen Breakdown of academic impact, for papers by Lars Køber Breakdown of academic impact, for papers by Gerasimos Filippatos
Rankless by CCL
2026